The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal Cancer
Abstract
HYPOTHESIS: Metabolic imaging by positron emission tomography (PET) using [18F]fluorodeoxyglucose will be more accurate than anatomic imaging by computed tomography (CT) for detection of recurrent colorectal cancer. More accurate staging of recurrent tumor by PET will lead to more appropriate management decisions. DESIGN: Prospective blinded study comparing PET with CT, using histologic diagnosis, serial CT imaging, and clinical follow-up as criterion standards, with a fully blinded, retrospective reinterpretation of PET studies. Changes in diagnosis resulting from PET findings were correlated with subsequent treatment and surgical findings. Potential cost savings resulting from use of PET for preoperative staging were calculated. SETTING: Private practice in an outpatient tertiary referral center. PATIENTS: A group of 155 consecutive patients with imaging for diagnosis or staging of recurrent colorectal cancer. Twenty-one patient (14%) were excluded due to lack of a criterion standard. Computed tomographic scans were available for comparison for 115 patients. RESULTS: Positron emission tomographic scan sensitivity and specificity were 93% and 98%, respectively, compared with 69% and 96% for CT. Ninety-five percent confidence intervals for the differences between the modalities were 16% to 32% for sensitivity and 1% to 5% for specificity. The sensitivity of both modalities varied with anatomic site of recurrence. Positron emission tomographic scans were true positive in 12 (67%) of 18 patients with elevated serum carcinoembryonic antigen levels and negative CT findings. In 23 (29%) of 78 preoperative studies in which CT showed a single site of recurrence, PET showed tumor at additional sites. At surgery, nonresectable, PET-negative tumor was found in 7 (17%) of 42 patients who had PET evidence of localized recurrence only. Potential savings resulting from demonstration of nonresectable tumor by PET were calculated at $3003 per preoperative study. CONCLUSIONS: Positron emission tomography was more sensitive and specific than CT for detection of recurrent colorectal cancer. Preoperative detection of nonresectable tumor by PET may avoid unnecessary surgery, and thereby reduce the cost of patient treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and Analysis: A Researcher's Handbook
Beaton, A. E., & Keppel, G. (1975) · American Educational Research Journal · doi:10.2307/1162588 · Cited by 5,822
The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?
Heald, R. J., Husband, E. M., & Ryall, R. D. H. (1982) · Journal of British Surgery · doi:10.1002/bjs.1800691019 · Cited by 2,917
Design and Analysis: A Researcher's Handbook
Aaker, D. A., & Keppel, G. (1976) · Journal of Marketing Research · doi:10.2307/3150757 · Cited by 2,011
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Rectal Cancer: The Basingstoke Experience of Total Mesorectal Excision, 1978-1997
Heald, R. J., Moran, B. J., Ryall, R. D. H., Sexton, R., & MacFarlane, J. K. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.8.894 · Cited by 1,399
Moertel, C. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080047030 · Cited by 449
Patterns of recurrence after curative resection of carcinoma of the colon and rectum.
Galandiuk, S., Wieand, H. S., Cg, M., Cha, S. S., Rj, F., Jh, P., & Wolff, B. G. (1992) · PubMed · Cited by 438
Steele, G., Bleday, R., Mayer, R. J., Lindblad, A., Petrelli, N., & Weaver, D. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1105 · Cited by 374
Incidence and patterns of recurrence following curative resection for colorectal carcinoma
Obrand, D. I., & Gordon, P. H. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02055676 · Cited by 319
International Classification of Diseases, Ninth Revision, Clinical Modification
National Cancer Institute (2020) · Definitions · doi:10.32388/ggn38l · Cited by 294
Cited by
(2001) · PubMed · Cited by 943
Fernandez, F. G., Drebin, J. A., Linehan, D. C., Dehdashti, F., Siegel, B. A., & Strasberg, S. M. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000138076.72547.b1 · Cited by 621
Kinkel, K., Lu, Y., Both, M., Warren, R. S., & Thoeni, R. F. (2002) · Radiology · doi:10.1148/radiol.2243011362 · Cited by 621
Niekel, M. C., Bipat, S., & Stoker, J. (2010) · Radiology · doi:10.1148/radiol.10100729 · Cited by 584
Clinical Role of FDG PET in Evaluation of Cancer Patients
Kostakoglu, L., Agress, H., & Goldsmith, S. J. (2003) · RadioGraphics · doi:10.1148/rg.232025705 · Cited by 402
Metadata
- Authors
- Valk, P. E.
- Venue
- Archives of Surgery
- Publisher
- American Medical Association (AMA)
- Published
- 1999-05-01
- Volume
- 134
- Issue
- 5
- Pages
- 503-511
- ISSN
- 0004-0010 (ISSN-L)
- OpenAlex
- W2093096127
- Cited by
- 291
- References
- 21
- FWCI
- 23.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal Cancer. https://app.cochat.ai/papers/10.1001/archsurg.134.5.503
- The paper
- Valk, P. E. (1999). Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal Cancer. Archives of Surgery. https://doi.org/10.1001/archsurg.134.5.503
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.